These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16142247)

  • 41. Synthesis and biological evaluation of a novel 99mTc(CO)3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection.
    Zhang J; Zhang S; Guo H; Wang X
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3781-4. PubMed ID: 20471828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of ciprofloxacin labelled with technetium Tc 99m versus 99mTc-pertechnetate to a live and killed equine isolate of Escherichia coil.
    Alexander K; Drost WT; Mattoon JS; Kowalski JJ; Funk JA; Crabtree AC
    Can J Vet Res; 2005 Oct; 69(4):272-7. PubMed ID: 16479725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications.
    Goldsmith SJ; Vallabhajosula S
    Semin Nucl Med; 2009 Jan; 39(1):2-10. PubMed ID: 19038596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Labeling of antibiotics for infection diagnosis.
    Benitez A; Roca M; Martin-Comin J
    Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):147-52. PubMed ID: 16770305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re: synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin.
    Tewson TJ
    J Nucl Med; 2005 Jun; 46(6):1077. PubMed ID: 15937322
    [No Abstract]   [Full Text] [Related]  

  • 46. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial.
    Akhtar MS; Qaisar A; Irfanullah J; Iqbal J; Khan B; Jehangir M; Nadeem MA; Khan MA; Afzal MS; Ul-Haq I; Imran MB
    J Nucl Med; 2005 Apr; 46(4):567-73. PubMed ID: 15809477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: methodological considerations-reply.
    Płachcińska A; Kuśmierek J
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):796. PubMed ID: 14963699
    [No Abstract]   [Full Text] [Related]  

  • 48. Imaging seminal vesiculitis with Tc-99m ciprofloxacin.
    Choe W; Kan Ryu J; Kim WH; Chung MH; Suh JK
    Clin Nucl Med; 2003 Jun; 28(6):501-2. PubMed ID: 12917536
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative evaluation of 99mTc-depreotide and 201Tl chloride single photon emission tomography in the characterization of pulmonary lesions.
    Boundas D; Karatzas N; Moralidis E; Arsos G; Drevelengas A; Pistevou-Gompaki K; Karakatsanis C
    Nucl Med Commun; 2007 Jul; 28(7):533-40. PubMed ID: 17538394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature.
    Stokkel MP; Duchateau CS; Dragoiescu C
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):78-87. PubMed ID: 16557207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Receptor targeting agents for imaging inflammation/infection: where are we now?
    Signore A; Chianelli M; D'Alessandria C; Annovazzi A
    Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):236-42. PubMed ID: 16868537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imaging of infection and inflammation with 99mTc-Fanolesomab.
    Love C; Tronco GG; Palestro CJ
    Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):113-20. PubMed ID: 16770301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An infected hip prosthesis in a dog diagnosed with a 99mTc-ciprofloxacin (infecton) scan.
    Peremans K; De Winter F; Janssens L; Dumont F; Van Bree H; Dierckx R
    Vet Radiol Ultrasound; 2002; 43(2):178-82. PubMed ID: 11954814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of FDG PET in the management of lymphoma: practical guidelines.
    Kirby AM; George Mikhaeel N
    Nucl Med Commun; 2007 May; 28(5):355-7. PubMed ID: 17414884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT.
    Kung HF; Kung MP; Wey SP; Lin KJ; Yen TC
    Nucl Med Biol; 2007 Oct; 34(7):787-9. PubMed ID: 17921030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical applications of 99mTc-sestamibi scintimammography.
    Taillefer R
    Semin Nucl Med; 2005 Apr; 35(2):100-15. PubMed ID: 15765373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of 18F-FDG PET in evaluating cancers of lung.
    Acker MR; Burrell SC
    J Nucl Med Technol; 2005 Jun; 33(2):69-74; quiz 75-7. PubMed ID: 15930019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The promise of immuno-PET in radioimmunotherapy.
    Verel I; Visser GW; van Dongen GA
    J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection.
    Britton KE; Vinjamuri S; Hall AV; Solanki K; Siraj QH; Bomanji J; Das S
    Eur J Nucl Med; 1997 May; 24(5):553-6. PubMed ID: 9142737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
    Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G
    Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.